Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin versus glimepiride added to metformin in elderly patients with type 2 diabetes
2009-012816-41Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2009
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Saxagliptin add-on to metformin with Glimepiride add-on to metformin (2 arms). Primary endpoint: Proportion of patients reaching HbA1c target <7% without hypoglycaemia. Started Jul 2009; status: completed.
02
Drugs
saxagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-012816-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012816-41.